Omnicell Inc(OMCL) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 4:00 PM ET (Korea 10/31 05:00)
Full metrics table
| Index | RUT | P/E | 38 | EPS (ttm) | 0.96 | Insider Own | 3.4% | Shs Outstand | 45.6M | Perf Week | -2.91% |
| Market Cap | 1.67B | Forward P/E | 17.8 | EPS next Y | -15.54% | Insider Trans | -1.35% | Shs Float | 44.1M | Perf Month | 9.6% |
| Enterprise Value | 1.52B | PEG | 1.44 | EPS next Q | 0.41 | Inst Own | 107.26% | Short Float | 7.41% | Perf Quarter | -2.66% |
| Income | 0.04B | P/S | 1.34 | EPS this Y | 50.46% | Inst Trans | 4.68% | Short Ratio | 5.23 | Perf Half Y | -14.37% |
| Sales | 1.24B | P/B | 1.29 | EPS next 5Y | 12.35% | ROA | 2.23% | Short Interest | 3.27M | Perf YTD | -19.09% |
| Book/sh | 28.32 | P/C | 4.95 | EPS past 3/5Y | -28.87% -43% | ROE | 3.52% | 52W High | -29.3% ($51.84) | Perf Year | 9.14% |
| Cash/sh | 7.4 | P/FCF | 11.66 | Sales past 3/5Y | -2.94% 5.84% | ROIC | 2.96% | 52W Low | 19.42% ($30.69) | Perf 3Y | 3.82% |
| Dividend Est. | - | EV/EBITDA | 9.81 | EPS Y/Y TTM | 126.76% | Gross Margin | 45.14% | Volatility(W/M) | 5.19% 3.77% | Perf 5Y | -79.43% |
| Dividend TTM | - | EV/Sales | 1.23 | Sales Y/Y TTM | 5.62% | Oper. Margin | 5.28% | ATR (14) | 1.41 | Perf 10Y | 12.42% |
| Dividend Ex-Date | - | Quick Ratio | 1.45 | EPS Q/Q | 99.75% | Profit Margin | 3.59% | RSI (14) | 55.48 | Recom | 1.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.66 | Sales Q/Q | -0.89% | SMA20 | 1.42% ($36.14) | Beta | 0.9 | Target Price | $58.43 |
| Payout | - | Debt/Eq | 0.14 | Earnings | 2026/10/29 | SMA50 | 5.91% ($34.6) | Rel Volume | 1.26 | Prev Close | $36.88 |
| Employees | 3580 | LT Debt/Eq | 0.14 | EPS/Sales Surpr. | 38.92% 1.12% | SMA200 | -6.11% ($39.04) | Avg Volume(3M) | 0.62M | Price | $36.65 |
| IPO | 2001/8/7 | Option/Short | Yes/Yes | Trades | 10600 | Volume | 785,186 | Change | -0.62% |
💊 A US healthcare technology company that provides automated medication management solutions for medical institutions. It combines automated drug dispensing and storage equipment, pharmacy robots, management software, and services to support hospitals and pharmacies in medication management and medication safety. The company has established itself as a healthcare technology provider that combines medication management automation with software and services.
Over the past 1 year, roughly in the middle
29% below its 1-year high.
Traded more than usual. That is 126% of its average volume.
OMCL earns at a steady pace
Of every $100 in sales, $5.28 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +50.5% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $981. Peers typically go for $1,412. Compared with its own 3-year average, it is 45% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 5 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -79.4%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 107.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #12 of 41 in the industry
Based on market cap of $2B.
SDGR#10 Schrodinger Inc $2B PER - 
CERT#11 Certara Inc $2B PER - OMCL#12 Omnicell Inc $2B PER 38.0 
TDOC#13 Teladoc Health Inc $2B PER - 
GDRX#14 GoodRx Holdings Inc $1B PER 74.1 
FAQ
What kind of company is OMCL?
OMCL belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of OMCL?
The market cap of OMCL is approximately $1.7B, ranking 2,198 within its sector.
What is the P/E ratio of OMCL?
OMCL has a P/E ratio of approximately 38.0x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for OMCL?
OMCL has recorded a 52-week high of $51.84 and a low of $30.69.
